Design and Physicochemical Characterization of a Multifunctional Maisine-Based Microemulsion Incorporating Doxorubicin@Mn-Doped Magnetite Nanoparticles for MRI, Hyperthermia, and Drug Delivery
Aug 2026· Nanomaterials· Vol 16· 0 citations· 81 references
Medicine
TL;DR
It is demonstrated that dopant-engineered MNPs combined with a ME carrier can provide a versatile platform for integrating magnetic hyperthermia potential, T2-weighted MRI contrast enhancement, and controlled chemotherapeutic delivery within a single nanostructured system.
Abstract
Multifunctional nanocarriers capable of integrating imaging, magnetic functionality, and controlled drug delivery represent an important research topic in cancer nanomedicine. Herein, Mn-doped (Fe3O4) magnetite nanoparticles (MNPs) were engineered and incorporated into a Maisine CC-based oil-in-water microemulsion (ME) to obtain a multifunctional nanoplatform for magnetic resonance imaging (MRI), hyperthermia, and controlled drug release. A series of Mn-doped MNPs (1–10% Mn:Fe3O4) was synthesized by coprecipitation. X-ray diffraction confirmed the preservation of the cubic spinel upon Mn incorporation. The Mn incorporation resulted in MNPs made of crystallites (~9–12 nm) whose magnetic properties were improved. Also, 10% Mn led to a very good magnetic heating efficiency under alternating magnetic fields with a specific absorption rate of ~111 W·g−1. The obtained MNPs proved to be T2-weighted MRI contrast agents, with an increase in the r2 values up to ~844 mM−1·s−1 after incorporation into ME. The optimized composition of Mn10% was subsequently loaded with doxorubicin (DOX) and integrated into ME. Drug-release studies revealed a biphasic profile, characterized by an initial burst phase followed by sustained release up to 48 h. These findings demonstrate that dopant-engineered MNPs combined with a ME carrier can provide a versatile platform for integrating magnetic hyperthermia potential, T2-weighted MRI contrast enhancement, and controlled chemotherapeutic delivery within a single nanostructured system.
The synergistic combination of green synthesis, magnetic targeting capability, pH-triggered drug release, and superior anticancer efficacy highlights Fe3O4@PEG-CUR-NPs as a promising nanotherapeutic platform for precision cancer treatment and advanced biomedical applications.
K. Vijayalakshmi, A. Kavitha, S. Ayyanaar· Applied Biochemistry and Bio...· 0 citations
Cancer theranostics urgently demands multifunctional nanomaterials capable of simultaneously enabling high-sensitivity imaging and multimodal synergistic therapy. In this study, a three-layer core–shell nanocomposite, NaYF4:Yb,Tm@NaGdF4:Eu@NH2-MIL-53(Fe), was designed and synthesized. The NaYF4:Yb,Tm nanoparticle core...
Xin-Yao Su, Wen Guo, Qun-Ming Zhou et al.· Molecules· 0 citations
This work is centered on the formulation of a magnetic, targeted drug delivery
system using cyclodextrin–polyethylene glycol–folate (CD-PEG-fol) polymer-coated hydroxyapatite
(HAp) nanoparticles with incorporated ytterbium ferrite/ytterbium iron nanoparticles for
targeted camptothecin delivery.
Yb-Fer-HAp na...
Kiruthiga Kaliyamoorthi, U. Tamboli, Sudhaker Raboni Grace et al.· Current Nanomaterials· 0 citations
Magnetic hyperthermia integrated with magnetic resonance imaging (MRI) requires nanoparticles that combine strong heating, T2 contrast, and hemocompatibility after systemic administration. Here, we prepared citrate-stabilized ferrite nanoparticles (Fe3O4, Co0.6Fe2.4O4, Zn0.3Fe2.7O4, and Zn0.35Mn0.25Fe2.4O4) in spherica...
Bahareh Rezaei, Md Shahriar, Shahriar Mostufa et al.· 0 citations
Biocompatible metal oxide nanoparticles (NPs) are promising materials for biointerfaces, wound healing, and theranostic applications owing to their multifunctional properties. Here, we report manganese‐doped TiO2 (Mn‐doped TiO2) nanozymes that integrate the chemical stability and biocompatibility of TiO2 with the redox...
Filip Kozłowski, Nayoung Kim, Hyunwoo Choi et al.· Advanced Materials Interface...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.